US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist
  • 1.200
  • +0.030+2.56%
Close May 6 16:00 ET
  • 1.210
  • +0.010+0.83%
Post 19:58 ET
20.18MMarket Cap-2.35P/E (TTM)

About MIRA Pharmaceuticals Company

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. The company was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Company Profile

SymbolMIRA
Company NameMIRA Pharmaceuticals
Listing DateAug 3, 2023
Issue Price7.00
Founded2020
CEOMr. Erez Aminov
MarketNASDAQ
Employees5
Fiscal Year Ends12-31
Address1200 Brickell Avenue,Suite 1950 No. 1183
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33131
Phone1-786-432-9792

Company Executives

  • Name
  • Position
  • Salary
  • Erez Aminov
  • Chairman of the Board and Chief Executive Officer
  • 1.67M
  • Michelle Yanez, M.B.A.
  • Chief Financial Officer, Secretary and Treasurer
  • 541.62K
  • Matthew Pratt Whalen
  • Independent Director
  • --
  • Edward MacPherson
  • Independent Director
  • --
  • Dr. Matthew Paul Del Giudice, M.D.
  • Independent Director
  • --
  • Dr. Denil Nanji Shekhat, M.D.
  • Independent Director
  • --

Market Insights

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More